E N D
1. Cord blood Banking Module 1
Session 2
2. Today’s topics Multiple pregnancies
What we know and don’t know about stem cells at the moment
Public / Family banking
3. Collection during multiple pregnancies Depends on kind of twin pregnancy
If 2 separate sacs, can be collected after each twin is born
If 1 sac, collect only AFTER the birth of the second twin
4. Multiple pregnancies Inter-villous circulation between twins can exist if only I sac is present
Quadruplets
As long as volume is sufficient, no problem
Labeling is critical especially if non-identical twins
Time of birth, birth weight, volume of collection Twin 1 and 2 or A, B and so on
5. Stem cell banking Bone Marrow
Qty of harvest larger
Engraftment faster
GVHR 75%
Contamination more
Tedious collection
Longer time to find donors
HLA typing –5/6 or 6/6
Limited supply
Shorter telomeres Cord blood
Harvest quantum less
Engraftment takes longer
GVHR 38%
Less contamination
Simple collection
Donor search time –halved
HLA match –3/6 or 4/6
Limitless supply
Longer telomeres
6. Disadvantages of UC Banking Quantity of stem cells less in harvest
Rate of engraftment is slower
Cord blood stem cells might harbour genetic mistakes.
Can be collected just once in a person’s lifetime.
7. HLA typing of cord blood 3/6 or 4/6 match sufficient only in malignant conditions
Perfect match preferable for non malignant conditions.
If only 3 or 4/6 match present DR matching vital
Likelihood of finding a CB donor match , more than a bone marrow match
8. Likelihood of HLA match Identical twin with same genetic complement - no match required
Sibling of same parents – 1 in 4 chance of 100% match
Parents – some degree of matching likely
ANYONE ELSE IN THE FAMILY- no predictions possible - similar to unrelated donors
9. Studies on Viability Proceedings of the National Academy of Sciences, Broxmeyer and his co-author – study conclusions
Human cord blood frozen in 1985 and 1986 was able to grow in laboratory cultures with the same vigour as fresh cord blood.
Such cells frozen for a decade and a half can be used successfully to treat patients.
10. Factors vital for transplant success
The number of cells per kilogram of the patient's body weight
b) HLA match
Conclusively proved by John Wagner's research.
11. What we know about stem cells Stem cells are attracted to the site of injury
Stem cells can be injected in several ways
Embryonic stem cells have a will of their own
Adult stem cells need to be manipulated ex vivo
Bone marrow stem cells less effective than cord blood stem cells – cell for cell as far as heamatopoietic properties
12. Some more known facts… Bone marrow has larger number of stem cells , hence engraftment is sooner, usually 2-3 weeks
Cord blood stem cells take about double the length
Post transplant period therefore critical with CB transplants – more care required
13. Umbilical cord – a treasure Outer lining – rich in epithelial and mesenchymal stem cells
Wharton’s Jelly – rich in mesenchymal stem cells
Cord blood – mainly heamatopoeitic stem cells, small amounts of mesenchymal stem cells
14. Homing and engraftment A study in the August 13 Science reveals that the inhibition or genetic deletion of the peptidase CD26 on donor stem cells increases transplantation efficiency.
A clue to a way to expand stem cells came from the observation that inhibition of CD26’s peptidase activity on the molecule CXCL12, which is though to be involved in the homing of stem cells, might therefore increase stem cell homing and engraftment.
Being studied in mice -Broxmeyer, lead author Kent Christopherson
15. Status of cord blood transplants Around 6000 transplants done world-wide
Around 20 done in India (reported cases)
5 done in Chennai (Thalassemia and Leukemia)
17. Ongoing Research Identifying factors affecting homing and engraftment
Cell expansion / ex vivo culture / “selective” cell differentiation techniques
Fat stem cell differentiation into other cell types
Olfactory Ensheathing cells (OEC) down differentiation
18. Distribution of banks world-wide
Around 100 of which 75 are public banks
40 in US,
30 in the UK,
20 in Asia and
10 in Australia 2002
19. Cord Blood Banks in India Already existing in chronological order
Reliance Life Sciences (2001)– Mumbai – Public mainly, private to a small extent-now increasing
Cryo Stem Karnataka (2003)- Bangalore – Private mainly
LC (2004) Chennai – ONLY one with franchisee model
To come soon
Histostem – tie up with Apollo (Public+Private)
Indian govt at PGI Chandigarh (Public)
Pacific Hospitals – Hyderabad (Singapore based) Public
20. Types of cord blood banks Public banks
Use not restricted.
No remuneration
collected
Usage subject to availability
Private banks
For use of the family
Facility paid for by the family
Availability guaranteed
21. Public Banking Form filling very critical – maternal history
No anonymous donor collections
Identity a must for follow up
Recipient will not know the source of sample
No remuneration given to donor
22. Public Banking contd… All samples positive for ANY test will be rejected
Greater the rejection – greater the loss to bank
40% average rejections in a public bank
Only public banking samples can be used for unrelated third party or for research
23. What LC plans to do Identify 2 / 3 hospitals, located fairly close to LC office to rush kits
Educate the hospital personnel about form filling and informed consent
If planned earlier- usual process followed – no fees collected
If in the last minute – hospital must have at least 2 kits as standby
24. Public Banking at LC Different coding for Ids
Sticker on cardboard box
Plastic box inside will have a different lid colour
HLA typing will be done immediately for all samples
No reports to be sent to donor